1962 - Fellow of the American Association for the Advancement of Science (AAAS)
John T. Kissel focuses on Surgery, Pathology, Internal medicine, Spinal muscular atrophy and Muscle biopsy. The Surgery study combines topics in areas such as Peripheral neuropathy, Anesthesia and Cohort. His Pathology study combines topics in areas such as Ataxia, Intention tremor, Complement component 5 and Complement membrane attack complex.
His biological study spans a wide range of topics, including Gastroenterology and Chronic inflammatory demyelinating polyneuropathy. Many of his research projects under Spinal muscular atrophy are closely connected to Nusinersen and Weight gain with Nusinersen and Weight gain, tying the diverse disciplines of science together. His work focuses on many connections between Muscle biopsy and other disciplines, such as Vasculitis, that overlap with his field of interest in Superficial peroneal nerve and Angiopathy.
His main research concerns Internal medicine, Physical therapy, Pathology, Spinal muscular atrophy and Clinical trial. The concepts of his Internal medicine study are interwoven with issues in Surgery and Cardiology. John T. Kissel works mostly in the field of Physical therapy, limiting it down to topics relating to Weakness and, in certain cases, Myotonia.
His work in the fields of SMN1 overlaps with other areas such as Nusinersen. John T. Kissel usually deals with Clinical trial and limits it to topics linked to Natural history and Family medicine. As a part of the same scientific family, John T. Kissel mostly works in the field of Randomized controlled trial, focusing on Myasthenia gravis and, on occasion, Eculizumab.
John T. Kissel mainly investigates Internal medicine, Clinical trial, Spinal muscular atrophy, Adverse effect and Physical medicine and rehabilitation. His Internal medicine study integrates concerns from other disciplines, such as Chronic inflammatory demyelinating polyneuropathy and Cardiology. His Clinical trial research is multidisciplinary, incorporating perspectives in Developmental Milestone, Family medicine, Respiratory care, Natural history and Muscular dystrophy.
John T. Kissel interconnects Compound muscle action potential, Intraclass correlation, Physical therapy and Rating scale in the investigation of issues within Spinal muscular atrophy. His research integrates issues of Neuromuscular disease, Bimagrumab and Surgery in his study of Adverse effect. The various areas that John T. Kissel examines in his Randomized controlled trial study include Prednisone and Thymectomy.
John T. Kissel mostly deals with Internal medicine, Adverse effect, Spinal muscular atrophy, Randomized controlled trial and Pediatrics. His Adverse effect research is multidisciplinary, incorporating perspectives in Anesthesia, Myotonic Disorder, Paramyotonia congenita and Ranolazine. His studies deal with areas such as Choking, Compound muscle action potential, Physical therapy and Sitting as well as Spinal muscular atrophy.
His Randomized controlled trial study integrates concerns from other disciplines, such as Edrophonium, Absolute risk reduction, Prednisone and Thymectomy. John T. Kissel interconnects Muscular dystrophy, Surgery and Intensive care medicine, Respiratory care in the investigation of issues within Clinical trial. The study incorporates disciplines such as Chronic inflammatory demyelinating polyneuropathy, Carnitine, Valproic Acid and Polyradiculoneuropathy in addition to Surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
Jerry R. Mendell;Samiah Al-Zaidy;Richard Shell;W. Dave Arnold.
The New England Journal of Medicine (2017)
Fragile X Premutation Tremor/Ataxia Syndrome: Molecular, Clinical, and Neuroimaging Correlates
Sébastien Jacquemont;Randi J. Hagerman;Maureen Leehey;Jim Grigsby.
American Journal of Human Genetics (2003)
Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria
Richard J. Barohn;John T. Kissel;John R. Warmolts;Jerry R. Mendell.
JAMA Neurology (1989)
Randomized trial of thymectomy in myasthenia gravis
Gil I Wolfe;Henry J Kaminski;Joshua R Sonnett;Inmaculada B Aban.
The New England Journal of Medicine (2016)
Myoblast Transfer in the Treatment of Duchenne's Muscular Dystrophy
Jerry R. Mendell;John T. Kissel;Anthony A. Amato;Wendy King.
The New England Journal of Medicine (1995)
Microvascular deposition of complement membrane attack complex in dermatomyositis.
John T. Kissel;Jerry R. Mendell;Kottil W. Rammohan.
The New England Journal of Medicine (1986)
Painful sensory neuropathy: prospective evaluation using skin biopsy.
M.I. Periquet;V. Novak;M.P. Collins;H.N. Nagaraja.
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
James F Howard;Kimiaki Utsugisawa;Michael Benatar;Hiroyuki Murai.
Lancet Neurology (2017)
Spinal muscular atrophy
Stephen J. Kolb;John T. Kissel.
Neurologic Clinics (2015)
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy.
J. R. Mendell;R. J. Barohn;M. L. Freimer;J. T. Kissel.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: